Programme Overview
The International Executive MBA at BBI Cambridge is meticulously designed for high-potential leaders at the intersection of biotechnology and corporate finance. This part time programme combines rigorous academic theory with practical, real-world applications, enabling participants to master the complexities of life sciences investment, strategic management, and corporate valuation.
Guided by world-class faculty and industry experts, candidates will gain a profound understanding of the global biotech ecosystem while cultivating the leadership skills necessary to drive innovation and sustainable growth in this rapidly evolving sector.
Programme at a Glance
Starting Date
28th April 2026
Duration
18 Months - Part Time
Average Age
33 Years
work expirience
> 5 years
Format
Online - Hybrid
Location
Cambridge & Online
Alumni Network
Global Connect
price
£ 12,500
Academic Excellence
Specialized Life Sciences Curriculum
✓
Industry-aligned modules bridging the gap between scientific innovation and corporate strategy.
World-Class Executive Faculty
✓
Learn from top-tier practitioners and researchers at the forefront of the global biotech sector.
Strategic Innovation Frameworks
✓
Master the quantitative tools required to evaluate and lead high-growth venture assets.
Global Professional Network
✓
Join a prestigious community of alumni and partners across Cambridge and international hubs.
Programme Syllabus
1st Term. Module I - The Life Sciences Commercial Ecosystem
Strategic analysis of global life sciences ecosystems, examining how science, capital markets, regulation and healthcare stakeholders interact to transform innovation into scalable, sustainable commercial and social value
1st Term. Module II - Drug Discovery and Regulatory Development
Executive-level understanding of scientific, clinical and regulatory pathways shaping medicines, medical devices and digital health technologies, integrating compliance, ethics and accelerated approval strategies across international jurisdictions
1st Term. Module III - Management in Research & Development
Strategic leadership of R&D organisations, addressing portfolio prioritisation, governance models, intellectual property strategy, resource allocation and performance management within high-risk, innovation-driven biotechnology and healthcare environments
2nd Term. Module IV - International Business Administration in Life Sciences
Comprehensive corporate management framework covering entrepreneurship, global strategy, biotech finance, valuation methodologies, licensing structures and international expansion across pharmaceuticals, medical devices and digital health markets
2nd Term. Module V - Business Development & Portfolio Management
Strategic evaluation of licensing, alliances and acquisitions to access external innovation, applying portfolio optimisation frameworks to balance risk, capital allocation and long-term competitive positioning
3rd Term. Module VI - Global Project Management
Executive oversight of complex global development programmes, coordinating regulatory milestones, cross-functional leadership, budget discipline and lifecycle strategy for drug approvals, device clearances and digital health solutions
3rd Term. Module VII - Global Marketing & Medical
Advanced analysis of healthcare commercial strategy, integrating medical affairs, evidence generation, brand positioning, omnichannel engagement and lifecycle management across highly regulated global markets
3rd Term. Module VIII - Market Access & Health Economics
Strategic integration of pricing, reimbursement and health technology assessment frameworks to secure sustainable patient access, aligning clinical differentiation with economic value across diverse healthcare systems
3rd Term. Module IX - Therapeutic Areas - Unmet Medical Need
Evaluation of global disease burden, epidemiology and unmet medical needs, linking emerging therapies, platform technologies and precision medicine approaches to strategic investment and development decisions
3rd Term. Module X - Converting Theory into Practice
Capstone strategic project applying financial, regulatory and commercial frameworks to real-world innovation opportunities within partner organisations or independent entrepreneurial initiatives, demonstrating executive-level decision-making and implementation capability
Hear from our Alumni
Our alumni are shaping the future of the global life sciences industry. From launching ventures and securing investment to advancing innovation and leading strategic growth, their achievements reflect the real-world impact of our executive programmes. Discover how our community turns knowledge into leadership and vision into measurable results.
Enrollment
- Application: Initial submission of professional credentials and academic transcripts through our secure portal.
- Review: Comprehensive evaluation by our Admissions Committee focusing on leadership potential and industry experience.
- Offer: Formal invitation to join the programme issued to selected candidates.
- Registration: Confirmation of place through enrollment documentation and initial tuition deposit.
Join the Next Cohort
ADMISSIONS
BBI Cambridge programmes are designed for ambitious professionals ready to lead at the intersection of science, innovation, and business. With rolling admissions, you can secure your place for the next intake and continue developing your expertise, advancing your career, expanding your impact, and shaping the future of the Life Sciences sector